VIRLIX 1MG/ML ORAL SOLUTION 30ML
Indications / Uses :
For the relief of: Nasal and ocular symptoms of seasonal and perennial allergic rhinitis. Symptoms of urticaria.
May be taken with or without food: FC tab: Swallow w/ a glass of liqd. Oral soln: Swallow as such. Oral drops: Dilute in liqd.
Cetirizine is contraindicated in: hypersensitivity to any of the constituents of this formulation, to hydroxyzine or to any piperazine derivatives, patients with severe renal impairment at less than 10 mL/min creatinine clearance.
Special Precautions :
Alcohol: At therapeutic doses, no clinically significant interactions have been demonstrated with alcohol (for a blood alcohol level of 0.5 g/L). Nevertheless, precaution is recommended if alcohol is taken concomitantly.
Increased risk of urinary retention: Caution should be taken in patients with predisposition factors of urinary retention (e.g. spinal cord lesion, prostatic hyperplasia) as cetirizine may increase the risk of urinary retention.
Patients at risk of convulsions: Caution in epileptic patients and patients at risk of convulsions is recommended.
Allergy skin tests: Allergy skin tests are inhibited by antihistamines and a wash-out period of 3 days is recommended before performing them.
Food: The extent of absorption of cetirizine is not reduced with food, although the rate of absorption is decreased.
Excipients: Lactose: Film-coated tablets, 10 mg: This product contains lactose. Patients with rare hereditary problems of galactose intolerance, (the Lapp lactase deficiency or glucose-galactose malabsorption) should not take this medicine.
Sorbitol: Oral solution, 1 mg/mL: This product contains sorbitol. Patients with rare hereditary problems of fructose intolerance should not take this medicine.
Sucrose: Oral solution, 1 mg/mL: This product contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucosegalactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
Parabens: Oral solution, 1 mg/mL and Oral drops, solution, 10 mg/mL: This product contains methylparahydroxybenzoate or propylparahydroxybenzoate, which may cause allergic reactions (possibly delayed).
Effects on ability to drive and use machines: Objective measurements of driving ability, sleep latency and assembly line performance have not demonstrated any clinically relevant effects at the recommended dose of 10 mg.
Patients intending to drive, engaging in potentially hazardous activities or operating machinery should not exceed the recommended dose and should take their response to the medicinal product into account.
In sensitive patients, concurrent use with alcohol or other CNS depressants may cause additional reductions in alertness and impairment of performance.
Use in Children: The use of the film-coated tablet formulation is not recommended in children aged less than 6 years since this formulation does not allow for appropriate dose adaptation. It is recommended to use a paediatric formulation of cetirizine.
Please be aware that in some markets, film-coated tablet may not be indicated in children below 12 years.